Related Experiment Video
Updated: Feb 17, 2026
10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
37.1K
Ebola virus disease: Biological and diagnostic evolution from 2014 to 2017
A Mérens1, C Bigaillon1, D Delaune1
1Laboratoire de biologie, hôpital d'instruction des Armées-Bégin, 69, avenue de Paris, 94160 Saint-Mandé, France.
Medecine Et Maladies Infectieuses
|December 12, 2017
Summary
The 2014-2016 Ebola virus disease outbreak advanced understanding of Ebola virus persistence and transmission. New diagnostic methods and clinical monitoring identified prognostic markers and pathophysiological consequences.
Area of Science:
- * Infectious Diseases
- * Virology
- * Public Health
Background:
- * The West Africa Ebola virus disease (EVD) outbreak (2014-2016) spurred significant research, increasing knowledge of the virus.
- * Patient treatment and imported cases necessitated advancements in diagnostics, laboratory organization, and biosafety.
- * Clinical and biological monitoring provided insights into EVD severity, prognosis, viral sanctuaries, and post-recovery transmission risks.
Purpose of the Study:
- * To summarize current knowledge on environmental and clinical Ebola virus persistence.
- * To present novel diagnostic methods and biological tests for EVD.
- * To highlight pathophysiological consequences and prognostic markers of EVD.
Main Methods:
- * Review of recent literature on Ebola virus persistence.
- * Description of new diagnostic and biological testing strategies for EVD.
- * Analysis of laboratory experiences and changes in patient care from 2014-2017.
Main Results:
- * Enhanced understanding of Ebola virus persistence in various environments and post-recovery.
- * Development and adaptation of new diagnostic tools and laboratory protocols for EVD.
- * Identification of key clinical and biological markers for EVD severity and prognosis.
Conclusions:
- * The EVD outbreak significantly advanced diagnostic capabilities and understanding of disease pathophysiology.
- * Prognostic markers and the risk of viral persistence/transmission after recovery were better defined.
- * Laboratory practices and biosafety measures were critically adapted to manage EVD patient care.
Related Concept Videos
00:36Viral Mutations
40.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
00:42Cross-reactivity
33.2K
Overview
33.2K
00:57Viral Recombination
25.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.2K